Nuvama PMS

Our view on their team, the pedigree, the funds & investment philosophy followed.

IME's Review of Nuvama PMS

AMC RatingPedigree RatingTeam RatingPhilosophy Rating
Upgrade
Upgrade
Upgrade
Upgrade
AMC Pedigree
Upgrade
Team Pedigree
Upgrade
FM Churn Risk
Upgrade
AMC Maturity
Upgrade
Philosphy Name
Upgrade
Inv Philosophy
Upgrade
Investment Team
Upgrade

AMC View

Nuvama PMS is not under our coverage.

AMC Pedigree

Team Pedigree

Investment team

Recommended Funds

No fund performance data available

Experience the benefits of working with a 'research-first' investments firm

Free 15-Day Trial of IME RMS App

Get complimentary access to the revolutionary IME RMS App (direct access to IME's central team insights across 1000's of MFs, PMSs, AIFs & Global funds - a first in the industry).

Additionally, a dedicated private banker will help build your financial plan, investment mandate & undertake a comprehensive portfolio review for free.

IME Capital Logo

IME Capital is a research-first investments firm. We aim to disrupt the wealth management industry, by shrinking the gap in investment insights between central research teams & RMs/Clients.

Contact Us

Follow Us

Disclaimer MF/PMS/AIF/Direct Equities are all subject to market risks. Please read the scheme information and other related documents carefully prior to investing. Past performance is not indicative of future returns. Please consider your specific investment requirements before choosing a fund or designing a portfolio that suits your needs. Market & other data on this site has been sourced from what are considered to be reliable sources. All views shared (product ratings, views on individual securities etc.) are the proprietary property of IME Capital and cannot be used in any form without explicit written consent. IME Capital Pvt. Ltd. makes no warranties or representations, express or implied, on products offered through the platform (and that of our partners) or on the correctness of data & views shared. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Detailed Disclaimer | © 2021 All rights reserved | ARN No: ARN-182445